Dopamine/serotonin receptor ligands. 131: Homologization of a benzindoloazecine-type dopamine receptor antagonist modulates the affinities for dopamine D1-D5 receptors

Journal of Medicinal Chemistry

Volumn 49, Issue 21, 2006, Pages 6408-6411

  Enzensperger, Christoph ^a   Lehmann, Jochen ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

7 METHYL 6,7,8,9,14,15 HEXAHYDRO 5H INDOLO[3,2F][3]BENZAZECINE; BENZINDOLOAZECINE DERIVATIVE; CALCIUM ION; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR; DOPAMINE 4 RECEPTOR; DOPAMINE 5 RECEPTOR; DOPAMINE RECEPTOR; DOPAMINE RECEPTOR BLOCKING AGENT; LE 300; LE CE 580; RADIOLIGAND; SEROTONIN ANTAGONIST; SEROTONIN RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CHEMICAL MODIFICATION; CHEMICAL REACTION; CYCLIZATION; DRUG ACTIVITY; DRUG RECEPTOR BINDING; DRUG SELECTIVITY; DRUG STRUCTURE; DRUG SYNTHESIS; HUMAN; HUMAN CELL; ISOTOPE LABELING; LIGAND BINDING; NONHUMAN; RECEPTOR AFFINITY; REDUCTION; RING OPENING;

ANIMALS; CALCIUM; CELL LINE; CRICETINAE; CRICETULUS; HETEROCYCLIC COMPOUNDS WITH 4 OR MORE RINGS; HUMANS; INDOLES; RADIOLIGAND ASSAY; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D2; RECEPTORS, DOPAMINE D3; RECEPTORS, DOPAMINE D4; RECEPTORS, DOPAMINE D5; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 33750128120     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm060213k     Document Type: Article

References (15)

1. 5-selective Dopamine Receptor Antagonist. J. Med. Chem. 2006, 49, 2110-2116.
2. Decker, M.; Lehmann, J. Dopamine Receptor Ligands. 11: LE-300- New Results on Its Ability to Antagonize the Discriminative Effect of Cocaine. Pharmazie 2006. in press.
3. Decker, M.; Schleifer, K.-J.; Nieger, M.; Lehmann, J. Dopamine/Serotonin Receptor Ligands. 8: The Dopamine Receptor Antagonist LE 300-Modelled and X-ray Structure Plus Further Pharmacological Characterization, Including Serotonin Receptor Binding, Biogenic Amine Transporter Testing and in Vivo Testings. Eur. J. Med. Chem. 2004, 39, 481-489.
4. 1-Like Receptor Antagonist. Naunyn-Schmiedeberg's Arch. Pharmacol. 2002, 366, 543-550.
5. Witt, T.; Hock, F. J.; Lehmann, J. 7-Methyl-6,7,8,9,14,15- hexahydro-5H-benz[iflindolo[2,3-g]azecine, a New Heterocyclic System and a New Lead Compound for Dopamine Receptor Antagonists. J. Med. Chem. 2000, 43, 2079-2081.
6. 5 Selective Antagonist. J. Med. Chem. 2006, 49, 760-769.
7. Crosby, D. G.; Byond, J. B.; Johnson, H. E.; Indole-3-alkanamides; J. Org. Chem. 1960, 25, 1826-1827.
8. Majima, R.; Hoshino, T. Synthet. Vers, in d. Indol-Gruppe (Synthetic Experiments in the Field of Indoles). Berichte 1925, 58, 2043-2046.
9. Markgraf, J. H.; Choi, B. Y. Oxidation of Benzyl Ethers via Phase Transfer Catalysis. Synth. Commun. 1999, 29 (14), 2405-2411
10. Odasso, G.; Winters, G. Idrazidi Ciclichi (Cyclic hydrazides). Farmaco 1977, 32, 159-172.
11. Krollpfeiffer, F.; Müller, A. Über Phenacylpyridinium- verbindungen (About Phenacylpyridinium Compounds). Berichte 1935, 68, 1169-1177.
12. Davies, S. G., Whitham, G. H. Indane-3a,4-oxide: Formation by Isomerisation. J. Chem. Soc., Perkin Trans. 1 1978, 1479-1481.
13. Decker, M.; Lehmann, J. Dopamine Receptor Ligands. 7: Novel 3-Substituted 5-Phenyl-1.2,3,4.5,6-hexahydro-azepino-[4,5-b]indoles as Ligands for the Dopamine Receptors. Arch. Pharm. Med. Chem. 2003, 336, 466-476.
14. Kassack, M. U.; Höfgen, B.; Lehmann, J.; Eckstein, N.; Quillan, J. M.; Sadee, W. Functional Screening of G Protein-Coupled Receptors by Measuring Intracellular Calcium with a Fluorescence Microplate Reader. J. Biomol. Screening 2002, 8, 233-246.
15. 50) of an Enzymatic Reaction. Biochem. Pharmacol. 1973, 22, 3099-3108.